Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06571669 · ClinicalTrials.gov registry record · NA

BOOM-IBD2 Pivotal Clinical Trial

A NA study of Ulcerative Colitis and Inflammatory Bowel Diseases, sponsored by Boomerang Medical.

Recruiting
Registry status
NA
Development phase
137
Enrollment target
10
Study locations

NCT06571669 is a NA study of Ulcerative Colitis and Inflammatory Bowel Diseases that is actively recruiting participants, run by Boomerang Medical. The registered enrollment target is 137 participants, below the 2,056-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (93% lower). The trial reports 10 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06571669, a NA study of Ulcerative Colitis and Inflammatory Bowel Diseases, is actively recruiting participants, sponsored by Boomerang Medical.

RECRUITING
Registry status
NA
Development phase
137 participants
Enrollment target
10
Study locations

Study Summary

The BOOM-IBD2 clinical trial is designed to evaluate the effectiveness of sacral neuromodulation for the treatment of IBD.

Conditions Studied

Ulcerative Colitis Inflammatory Bowel Diseases

Interventions

  • DEVICE Neuromodulation

Study Locations (10)

California

  • Center for Colorectal Innovation - Los Angeles
  • Hoag Hospital - Newport Beach
  • PAMF (Palo Alto Medical Foundation) - Palo Alto

Texas

  • Objective Health - Amarillo - Amarillo
  • Objective Health - Central Texas - Waco

Kansas

  • Kansas Gastro - Wichita

Missouri

  • Objective Health - St. Louis - St Louis

Nevada

  • Las Vegas Medical Research LLC, DBA Vector Clinical Trials - Las Vegas

New York

  • Columbia University Irving Medical Center/New York Presbyterian Hospital - New York

North Carolina

  • UNC Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 137 participants
Start Date 2025-01-31
Est. Completion 2026-10
Phase NA

Sponsor

Boomerang Medical

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06571669

The ClinicalTrials.gov registry entry for NCT06571669 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,056-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (93% lower). The listed sponsor is Boomerang Medical, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 1 intervention - of which Neuromodulation is the first listed.

NCT06571669 reports 10 study locations spanning 7 distinct geographic areas - top geographies include California, Texas, Kansas.

Frequently Asked Questions

What is clinical trial NCT06571669 about?

NCT06571669 is a clinical study titled "BOOM-IBD2 Pivotal Clinical Trial". The BOOM-IBD2 clinical trial is designed to evaluate the effectiveness of sacral neuromodulation for the treatment of IBD.

What is the current status of trial NCT06571669?

This trial is currently recruiting. It is a NA study. The enrollment target is 137 participants. The study started on 2025-01-31. Estimated completion is 2026-10.

What conditions does trial NCT06571669 study?

This clinical trial studies the following conditions: Ulcerative Colitis, Inflammatory Bowel Diseases.

What interventions are being tested in trial NCT06571669?

The interventions under investigation include: Neuromodulation (DEVICE).

Who is sponsoring clinical trial NCT06571669?

This trial is sponsored by Boomerang Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06571669 being conducted?

This trial has 10 study locations across California, Kansas, Missouri, Nevada, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ulcerative Colitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ulcerative Colitis

All registered trials for this condition

Inflammatory Bowel Diseases

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.